PL375183A1 - Analogi aminokwasów radioaktywnie znaczone, ich wytwarzanie i zastosowanie - Google Patents

Analogi aminokwasów radioaktywnie znaczone, ich wytwarzanie i zastosowanie

Info

Publication number
PL375183A1
PL375183A1 PL03375183A PL37518303A PL375183A1 PL 375183 A1 PL375183 A1 PL 375183A1 PL 03375183 A PL03375183 A PL 03375183A PL 37518303 A PL37518303 A PL 37518303A PL 375183 A1 PL375183 A1 PL 375183A1
Authority
PL
Poland
Prior art keywords
preparation
amino acid
acid analogues
radioactively labelled
labelled amino
Prior art date
Application number
PL03375183A
Other languages
English (en)
Inventor
John J.R. Mertens
Original Assignee
Mallinckrodt Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc. filed Critical Mallinckrodt Inc.
Publication of PL375183A1 publication Critical patent/PL375183A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03375183A 2002-08-02 2003-08-01 Analogi aminokwasów radioaktywnie znaczone, ich wytwarzanie i zastosowanie PL375183A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02078228 2002-08-02

Publications (1)

Publication Number Publication Date
PL375183A1 true PL375183A1 (pl) 2005-11-28

Family

ID=33547582

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375183A PL375183A1 (pl) 2002-08-02 2003-08-01 Analogi aminokwasów radioaktywnie znaczone, ich wytwarzanie i zastosowanie

Country Status (10)

Country Link
US (2) US7189383B2 (pl)
EP (1) EP1539250A1 (pl)
JP (1) JP2006516547A (pl)
KR (1) KR20050033067A (pl)
CN (1) CN100581589C (pl)
AU (1) AU2003304200B2 (pl)
CA (1) CA2494704A1 (pl)
IL (1) IL166577A0 (pl)
PL (1) PL375183A1 (pl)
WO (1) WO2004110500A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1764352A1 (en) * 2005-08-17 2007-03-21 Institute of Nuclear Energy Research A conventional method for the preparation of new precursor of no-carrier-adde O-(2-[18F]fluoroethyl)-L-tyrosine
JP2007112725A (ja) * 2005-10-18 2007-05-10 Inst Nuclear Energy Research Rocaec 無支持体の１８Ｆで標識したアミノ酸Ｏ−（２−［１８Ｆ］ｆｌｕｏｒｏｅｔｈｙｌ）−Ｌ−Ｔｙｒｏｓｉｎｅの製造方法。
US20080293969A1 (en) * 2005-11-22 2008-11-27 Ge Healthcare Limited 18F-Labeled Daa Analogues and Method of Labeling These Analogues as Positron Emission Tomography (Pet) Tracers For Imaging Peripheral Benzodiazepine Receptors
KR101495924B1 (ko) * 2006-11-01 2015-02-25 바이엘 파마 악티엔게젤샤프트 [ｆ-１８]-표지된 ｌ-글루탐산, [ｆ-１８]-표지된 ｌ-글루타민, 이들의 유도체 및 이들의 용도 및 이들의 제조 방법
EP1923382A1 (de) * 2006-11-18 2008-05-21 Bayer Schering Pharma Aktiengesellschaft [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123621A1 (de) 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
CA2724462A1 (en) * 2008-03-10 2009-09-17 Mcw Research Foundation, Inc. 99mtc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
EP2123619A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
CN101723849B (zh) * 2008-10-10 2012-11-21 北京师范大学 18f标记氨基酸类衍生物、其制备方法及其制备报告肿瘤的正电子发射断层显像分子探针中的应用
CN101723850B (zh) * 2008-10-10 2012-11-21 北京师范大学 18f标记芳香氨基酸及其制备方法和肿瘤显像应用
SG195545A1 (en) 2008-10-10 2013-12-30 Merck & Cie 18f-labelled folates as pet radiotracers
CA2745364A1 (en) * 2008-12-04 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
US8722014B2 (en) * 2009-05-01 2014-05-13 Washington University 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
JP5590540B2 (ja) * 2009-05-13 2014-09-17 国立大学法人東北大学 ポジトロン標識タンパク質の合成方法
MX2012005733A (es) * 2009-11-17 2013-01-22 Bayer Ip Gmbh Metodo de produccion de derivados de acido glutamico marcados con f-18.
WO2014126071A1 (ja) * 2013-02-12 2014-08-21 国立大学法人大阪大学 芳香族アミノ酸誘導体およびそれを用いるｐｅｔプローブ
JPWO2015152128A1 (ja) * 2014-03-31 2017-04-13 長瀬産業株式会社 アミノ酸前駆体、アミノ酸およびその製造方法、ならびに該アミノ酸を用いたｐｅｔ診断用トレーサー
JP6448231B2 (ja) * 2014-06-27 2019-01-09 浜松ホトニクス株式会社 放射性標識化合物
CA3034757A1 (en) * 2016-08-23 2018-03-01 Simon Fraser University 18f labeled amino acids, derivatives thereof and method of making same
US20210000988A1 (en) * 2018-03-15 2021-01-07 Osaka University Pharmaceutical composition containing 211at-labeled amino acid derivative, and method for producing said pharmaceutical composition
CN109091681B (zh) * 2018-08-09 2021-08-03 中山大学附属第一医院 [18f]三氟甲基含硫氨基酸类pet显像剂及其制备方法和应用
CN116655670A (zh) * 2023-05-22 2023-08-29 中国科学院近代物理研究所 一种基于氨基酸转运体作用机制的化合物及其合成方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1220591A (en) * 1914-05-22 1917-03-27 Guggenheim Laundry Machinery Company Laundry machinery.
GB1220591A (en) * 1967-05-26 1971-01-27 Rit Rech Ind Therapeut Beta-phenylalanine derivatives
BE720365A (pl) * 1967-09-11 1969-02-17
DE2818644C2 (de) * 1978-04-27 1983-09-29 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mit radioaktivem Jod markierte 3'-Brom-thyrocarbonsäurederivate und Verfahren zu deren Herstellung
EP0451422A1 (en) * 1990-04-13 1991-10-16 Merrell Dow Pharmaceuticals Inc. Pharmaceutically active fluoromethyltyrosine compounds
JP3537914B2 (ja) * 1995-05-18 2004-06-14 株式会社生体機能研究所 ［１８ｆ］フルオロ芳香族化合物の製造法
AU9375698A (en) * 1997-09-03 1999-03-22 Immunomedics Inc. Fluorination of proteins and peptides for f-18 positron emission tomography
DE10223451A1 (de) * 2002-05-25 2003-12-24 Abx Gmbh Verfahren zur Herstellung von 18F-fluorierten alpha-Aminosäuren

Also Published As

Publication number Publication date
EP1539250A1 (en) 2005-06-15
WO2004110500A1 (en) 2004-12-23
CN100581589C (zh) 2010-01-20
KR20050033067A (ko) 2005-04-08
AU2003304200A1 (en) 2005-01-04
US7189383B2 (en) 2007-03-13
AU2003304200B2 (en) 2009-10-01
CA2494704A1 (en) 2004-12-23
IL166577A0 (en) 2006-01-15
JP2006516547A (ja) 2006-07-06
US20060127306A1 (en) 2006-06-15
US20070081941A1 (en) 2007-04-12
CN1674943A (zh) 2005-09-28

Similar Documents

Publication Publication Date Title
IL166577A0 (en) Radioactively labelled amino acid analogues their preparation and use
AU2003256963A8 (en) Patient scheduling, tracking and status system
PL374821A1 (pl) Analogi tiomolibdenianowe i ich zastosowanie
AU2003274211A8 (en) Flame-retardant composition, preparation method and use thereof
PL372814A1 (pl) Tiazolidyno-4-karbonitryle i analogi oraz ich zastosowanie jako inhibitory dipeptydylo-peptydaz
IL165588A0 (en) Malonitrile compound and use thereof
EP1550657A4 (en) AMINO COMPOUNDS AND THEIR USE
EP1560569A4 (en) GASTRORETENTIVE LEVODOPA DELIVERY FORM
AU2003257113A8 (en) Nail care system
AU2003221704A8 (en) Immunogenic peptides, and method of identifying same
GB0305013D0 (en) Oblique-view cone-beam CT system
AU2003254844A1 (en) Substituted amino compounds and use thereof
TWI346135B (en) Epoxy compound, preparation method thereof, and use thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
EP1550459A4 (en) PARAKERATOSIS HEMMER, POROUS AGENT AND SKIN PREPARATION FOR TOPICAL APPLICATION
SG106109A1 (en) Tomography or curved surfaces
IL172195A0 (en) Thiotungstate analogues and uses thereof
EP1568704A4 (en) NOVEL 2 ', 5'-OLIGOADENIC ACID ANALOG
AU2003210778A8 (en) Amino acid transporters
PL376148A1 (pl) Analogi witaminy D, kompozycje zawierające te analogi oraz ich zastosowanie
ZA200500921B (en) Thiomolybdate analogues and uses thereof
EP1487459A4 (en) PEPTIDE ANALOGUES AND USES
GB0229445D0 (en) Process,composition and use
IL149851A0 (en) Resistin binding proteins, their preparation and use
IL151980A0 (en) Resistin binding proteins, their preparation and use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)